Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
7.07M
-
Shares change
-
+327K
-
Total reported value, excl. options
-
$20.1M
-
Value change
-
+$875K
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$2.78
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2016
15 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q2 2016.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.07M shares
of 131M outstanding shares and own 5.41% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (2.55M shares), GREAT POINT PARTNERS LLC (2.46M shares), BAKER BROS. ADVISORS LP (711K shares), EverPoint Asset Management, LLC (600K shares), Abingworth LLP (512K shares), Lombard Odier Asset Management (USA) Corp (102K shares), MILLENNIUM MANAGEMENT LLC (50K shares), RENAISSANCE TECHNOLOGIES LLC (41.1K shares), Redmile Group, LLC (28.4K shares), and ROYAL BANK OF CANADA (10.8K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.